UBS Group’s Procaps Group, S.A. Ordinary Shares PROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49
Closed -$115 11020
2024
Q4
$115 Buy
+49
New +$91 ﹤0.01% 9636
2024
Q2
Sell
-42
Closed -$122 10272
2024
Q1
$122 Sell
42
-30,986
-100% -$112K ﹤0.01% 8807
2023
Q4
$126K Buy
+31,028
New +$90.4K ﹤0.01% 6051
2023
Q3
Sell
-1
Closed -$4 10104
2023
Q2
$4 Buy
+1
New +$4 ﹤0.01% 8776
2023
Q1
Sell
-852
Closed -$4.47K 10613
2022
Q4
$4.47K Buy
+852
New +$5.56K ﹤0.01% 9332
2022
Q3
Sell
-50
Closed 11087
2022
Q2
$0 Sell
50
-1,035
-95% -$8.58K ﹤0.01% 11107
2022
Q1
$9K Buy
1,085
+73
+7% +$657 ﹤0.01% 8575
2021
Q4
$10K Buy
1,012
+970
+2,310% +$9.46K ﹤0.01% 8810
2021
Q3
$0 Buy
+42
New +$428 ﹤0.01% 10217

UBS Group's PROC Position: Q1 2025 in Review

UBS Group sold out of Procaps Group, S.A. Ordinary Shares (PROC) in Q1 2025, closing a stake of 49 shares — an estimated $115 sold.

UBS Group first reported a position in PROC in Q3 2021 and held it in 9 quarters. The position peaked at $126K in Q4 2023. 0 funds tracked by Wall St. Rank hold PROC as of Q1 2025.

  • UBS Group reported no remaining Procaps Group, S.A. Ordinary Shares position as of Q1 2025 after selling out during the quarter.
  • UBS Group sold 49 Procaps Group, S.A. Ordinary Shares shares in Q1 2025, an estimated $115.
  • UBS Group first reported a position in Procaps Group, S.A. Ordinary Shares in Q3 2021 and held it in 9 quarters.
  • UBS Group's Procaps Group, S.A. Ordinary Shares position peaked at $126K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Procaps Group, S.A. Ordinary Shares as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.